Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Switch (Belgium)

2004 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of cytology and histology reagents. The company manufactures cytology and histology reagents, dyes and products under the Q-Path brand.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Parent Company
Primary Office
  • Legen Heirweg 20D
  • 9890 Gavere
  • Belgium

+32 09 000 00 00

Switch (Belgium) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Switch (Belgium)‘s full profile, request access.

Request full access to PitchBook